Fibroblast activation protein regulates tumor-associated fibroblasts and epithelial ovarian cancer cells

International Journal of Oncology

Volumn 41, Issue 2, 2012, Pages 541-550

  Lai, Dongmei ^a   Ma, Li ^b   Wang, Fangyuan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Fibroblast activation protein; Microenvironment; Ovarian epithelial cancer; Tumor associated fibroblast

Indexed keywords

BETA ACTIN; CD133 ANTIGEN; DESMIN; FIBROBLAST GROWTH FACTOR; LENTIVIRUS VECTOR; NESTIN; OCTAMER TRANSCRIPTION FACTOR 4; SEPRASE; SMALL INTERFERING RNA; SMOOTH MUSCLE ACTIN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; VASCULOTROPIN; VIMENTIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER STEM CELL; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL STRUCTURE; CONTROLLED STUDY; FEMALE; FIBROBLAST; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; NONHUMAN; OVARY CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT;

ABNORMAL KARYOTYPE; ANIMALS; ANTIGENS, DIFFERENTIATION; CELL SHAPE; CHROMOSOME ABERRATIONS; FEMALE; FIBROBLASTS; G2 PHASE CELL CYCLE CHECKPOINTS; GELATINASES; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, GLANDULAR AND EPITHELIAL; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SERINE ENDOPEPTIDASES; TUMOR BURDEN; TUMOR CELLS, CULTURED; TUMOR MICROENVIRONMENT;

EID: 84863582019     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1475     Document Type: Article

References (32)

1. Kunz-Schughart LA and Knuechel R: Tumor-associated fibroblasts (part I): active stromal participants in tumor development and progression? Histol Histopathol 17: 599-621, 2002. (Pubitemid 34411214)
2. Kunz-Schughart LA and Knuechel R: Tumor-associated fibroblasts (part II): functional impact on tumor tissue. Histol Histopathol 17: 623-637, 2002. (Pubitemid 34411215)
3. Orimo A, Gupta PB, Sgroi DC, et al: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348, 2005. (Pubitemid 40692295)
4. Rowley DR: What might a stromal response mean to prostate cancer progression? Cancer Metastasis Rev 17: 411-419, 1998.
5. Ostermann E, Garin-Chesa P, Heider KH, et al: Effective immunoconjugate therapy in cancer models targeting a serine protease of tumor fibroblasts. Clin Cancer Res 14: 4584-4592, 2008.
6. Garin-Chesa P, Old LJ and Rettig WJ: Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc Natl Acad Sci USA 87: 7235-7239, 1990.
7. Christiansen V, Jackson KW, Lee KN and McKee PA: Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, III, and IV. Arch Biochem Biophys 457: 177-186, 2007. (Pubitemid 46048698)
8. Aggarwal S, Brennen WN, Kole TP, et al: Fibroblast activation protein peptide substrates identified from human collagen I derived gelatin cleavage sites. Biochemistry 47: 1076-1086, 2008.
9. Piñeiro-Sánchez ML, Goldstein LA, Dodt J, et al: Identification of the 170-kDa melanoma membrane-bound gelatinase (seprase) as a serine integral membrane protease. J Biol Chem 272: 7595-7601, 1997. (Pubitemid 27137306)
10. Park JE, Lenter MC, Zimmermann RN, et al: Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem 274: 36505-36512, 1999.
11. Santos AM, Jung J, Aziz N, Kissil JL and Puré E: Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. J Clin Invest 119: 3613-3625, 2009.
12. Liu T, Cheng WW, Lai DM, Huang Y and Guo LH: Characterization of primary ovarian cancer cells in different culture systems. Oncol Rep 23: 1277-1284, 2010.
13. Ma L, Lai DM, Liu T, Cheng WW and Guo LH: Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3. Acta Biochim Biophys Sin 42: 593-602, 2010.
14. Giannoni E, Bianchini F, Calorini L and Chiarugi P: Associated fibroblasts exploit reactive oxygen species through a proinflammatory signature leading to epithelial mesenchymal transition and stemness. Antioxid Redox Signal 14: 2361-2371, 2011.
15. Studeny M, Marini FC, Champlin RE, et al: Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 62: 3603-3608, 2002. (Pubitemid 34728832)
16. Nakamizo A, Marini F, Amano T, et al: Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65: 3307-3318, 2005. (Pubitemid 40524615)
17. Al-Hajj M and Clarke MF: Self-renewal and solid tumor stem cells. Oncogene 23: 7274-7282, 2004. (Pubitemid 39382161)
18. Fang D, Nguyen TK, Leishear K, et al: A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65: 9328-9237, 2005.
19. Bapat SA, Mali AM, Koppikar CB and Kurrey NK: Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res 65: 3025-3029, 2005. (Pubitemid 40524578)
20. Baglole CJ, Maggirwar SB, Gasiewicz TA, et al: The aryl hydrocarbon receptor attenuates tobacco smoke-induced cyclooxygenase-2 and prostaglandin production in lung fibroblasts through regulation of the NF-kappaB family member RelB. J Biol Chem 283: 28944-28957, 2008.
21. Trimboli AJ, Cantemir-Stone CZ, Li F, et al: Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 461: 1084-1091, 2009.
22. Studeny M, Marini FC, Dembinski JL, et al: Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 96: 1593-1603, 2004. (Pubitemid 39534883)
23. Spaeth EL, Dembinski JL, Sasser AK, et al: Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 4: e4992, 2009.
24. Mimeault M and Batra SK: Interplay of distinct growth factors during epithelial mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies. Ann Oncol 18: 1605-1619, 2007. (Pubitemid 47506246)
25. Giannoni E, Bianchini F, Masieri L, et al: Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. Cancer Res 70: 6945-6956, 2010.
26. Pirzio LM, Freulet-Marrière MA, Bai Y, et al: Human fibroblasts expressing hTERT show remarkable karyotype stability even after exposure to ionizing radiation. Cytogenet Genome Res 104: 87-94, 2004. (Pubitemid 38721057)
27. Cheng JD, Dunbrack RL Jr, Valianou M, et al: Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model. Cancer Res 62: 4767-4772, 2002.
28. Cheng JD, Valianou M, Canutescu AA, et al: Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth. Mol Cancer Ther 4: 351-360, 2005. (Pubitemid 40443920)
29. Mentlein R, Hattermann K, Hemion C, Jungbluth AA and Held-Feindt J: Expression and role of the cell surface protease seprase/fibroblast activation protein-á (FAP-á) in astroglial tumors. Biol Chem 392: 199-207, 2011.
30. Littlepage LE, Egeblad M and Werb Z: Coevolution of cancer and stromal cellular responses. Cancer Cell 7: 499-500, 2005. (Pubitemid 40799241)
31. Lazarides E, Granger BL, Gard DL, et al: Desmin- and vimentin-containing filaments and their role in the assembly of the Z disk in muscle cells. Cold Spring Harbor Symp Quant Biol 46: 351-378, 1982. (Pubitemid 12033480)
32. Kraman M, Bambrough PJ, Arnold JN, et al: Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha. Science 330: 827-830, 2010.